Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study

被引:42
|
作者
Syrigos, Konstantinos [1 ]
Grapsa, Dimitra [1 ]
Sangare, Rabiatou [2 ]
Evmorfiadis, Ilias [2 ]
Larsen, Annette K. [2 ]
Van Dreden, Patrick [3 ]
Boura, Paraskevi [1 ]
Charpidou, Andriani [1 ]
Kotteas, Elias [1 ]
Sergentanis, Theodoros N. [4 ]
Elalamy, Ismail [2 ,5 ]
Falanga, Anna [6 ,7 ]
Gerotziafas, Grigoris T. [2 ,5 ]
机构
[1] Univ Athens, Dept Med 3, Oncol Unit, Sch Med,Sotiria Gen Hosp, Athens, Greece
[2] Sorbonne Univ, Fac Med, Ctr Rech St Antoine, Canc Biol & Therapeut,INSERM,U938,IUC, Paris, France
[3] Diagnost Stago, Clin Res Dept, Gennevilliers, France
[4] Hop Univ Est Parisien, Hop Tenon, AP HP, Serv Hematol Biol, Paris, France
[5] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
[6] ASST Papa Giovanni XXIII, Dept Immunohematol & Transfus Med, Bergamo, Italy
[7] ASST Papa Giovanni XXIII, Hemostasis & Thrombosis Ctr, Bergamo, Italy
关键词
Lung cancer; Venous thromboembolism; Thrombin generation; Cancer-associated thrombosis; Risk assessment model; PATIENTS RECEIVING CHEMOTHERAPY; VENOUS THROMBOEMBOLISM VTE; PREDICTION; VALIDATION; SCORE; PROPHYLAXIS; ISSUES;
D O I
10.1634/theoncologist.2017-0530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The aim of this prospective study was to identify the most clinically relevant hypercoagulability biomarkers in lung adenocarcinoma patients for elaboration of an improved risk assessment model (RAM) for venous thromboembolism (VTE). Subjects, Materials, and Methods Results One hundred fifty ambulatory patients with lung adenocarcinoma were prospectively enrolled. Thrombin generation, procoagulant phospholipid-dependent clotting time (Procoag-PPL), tissue factor activity (TFa), factor VIIa (FVIIa), factor V (FV), antithrombin, D-Dimers, P-selectin, and heparanase levels were assessed in platelet-poor plasma at inclusion (baseline) and at the end of the third chemotherapy cycle (third chemotherapy). Cox regression analysis was used to identify independent VTE predictors. At baseline, patients had significantly attenuated thrombin generation, shorter Procoag-PPL, higher levels of TFa, D-Dimers, and heparanase, and lower levels of FVIIa and P-selectin, compared with controls. A significant increase in Procoag-PPL, FV, and FVIIa and a decrease of P-selectin levels were observed between baseline and third chemotherapy. Hospitalization within the last 3 months prior to assessment, time since cancer diagnosis less than 6 months, mean rate index (MRI) of thrombin generation, and Procoag-PPL were independently associated with symptomatic VTE. Accordingly, a prediction model including Procoag-PPL and MRI showed significant discriminating capacity (area under the curve: 0.84). Conclusion Implications for Practice Ambulatory patients with lung adenocarcinoma may display pronounced blood hypercoagulability due to decreased Procoag-PPL, increased endothelial cell activation, and increased degradation of fibrin. Incorporation of Procoag-PPL and MRI of thrombin generation may improve the accuracy of a VTE-RAM in the above setting.
引用
收藏
页码:1372 / 1381
页数:10
相关论文
共 50 条
  • [21] Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis
    Frere, Corinne
    Font, Carme
    Esposito, Francis
    Crichi, Benjamin
    Girard, Philippe
    Janus, Nicolas
    SUPPORTIVE CARE IN CANCER, 2022, 30 (04) : 2919 - 2931
  • [22] Symptoms of Posttraumatic Stress Disorder and Associated Risk Factors in Patients With Lung Cancer: A Longitudinal Observational Study
    Ni, Jun
    Feng, Jian
    Denehy, Linda
    Wu, Yi
    Xu, Liqin
    Granger, Catherine L.
    INTEGRATIVE CANCER THERAPIES, 2018, 17 (04) : 1195 - 1203
  • [23] Comparison of risk prediction scores for cancer-associated thrombosis in ambulatory cancer patients not receiving thromboprophylaxis: A prospective cohort study in a South-East Asian population
    Thipbumrung, Sittikul
    Niprapan, Piangrawee
    Suprasert, Prapaporn
    Ketpueak, Thanika
    Tantiworawit, Adisak
    Punnachet, Teerachat
    Hantrakun, Nonthakorn
    Piriyakhuntorn, Pokpong
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Rattarittamrong, Ekarat
    Norasetthada, Lalita
    Chai-Adisaksopha, Chatree
    THROMBOSIS RESEARCH, 2023, 232 : 138 - 144
  • [24] Risk Assessment of Deep-Vein Thrombosis After Acute Stroke: a Prospective Study Using Clinical Factors
    Liu, Li-Ping
    Zheng, Hua-Guang
    Wang, David. Z.
    Wang, Yi-Long
    Hussain, Mohammed
    Sun, Hai-Xin
    Wang, An-Xin
    Zhao, Xing-Quan
    Dong, Ke-Hui
    Wang, Chun-Xue
    He, Wen
    Ning, Bin
    Wang, Yong-Jun
    CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (05) : 403 - 410
  • [25] Validation of a modified Caprini risk assessment model in lung cancer patients undergoing surgery: Results of a multicenter cross-sectional observational study
    Ke, Lihui
    Cui, Songping
    Yang, Mei
    Chen, Jun
    Xu, Shun
    Jiang, Gening
    Zhang, Yi
    Chen, Shuo
    Zheng, E.
    Zhao, Honglin
    Fan, Xiaoxi
    Li, Yuping
    Zhi, Xiuyi
    Hu, Bin
    Li, Hui
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (05) : 933 - 942
  • [26] Development, validation, and clinical utility of risk prediction models for cancer-associated venous thromboembolism: A retrospective and prospective cohort study
    Jin, Shuai
    Qin, Dan
    Wang, Chong
    Liang, Baosheng
    Zhang, Lichuan
    Gao, Weiyin
    Wang, Xiao
    Jiang, Bo
    Rao, Benqiang
    Shi, Hanping
    Liu, Lihui
    Lu, Qian
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2025, 12
  • [27] Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study
    Kouvela, Marousa
    Livanou, Maria Effrosyni
    Stefanou, Dimitra T.
    Vathiotis, Ioannis A.
    Sarropoulou, Fotini
    Grammoustianou, Maria
    Dimakakos, Evangelos
    Syrigos, Nikolaos
    CANCERS, 2024, 16 (07)
  • [28] Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies
    Louzada, Martha L.
    Majeed, Habeeb
    Dao, Vi
    Wells, Philip S.
    BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (02) : 86 - 91
  • [29] Clinical Characteristics and Risk Factors of Patients with Lung Cancer Complicated with Pulmonary Embolism: A Case Control Study
    Wang, Pengfei
    Liang, Lei
    Ma, Kejing
    Duan, Wei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2025, 31
  • [30] Statins are Associated with Low Risk of Venous Thromboembolism in Patients with Cancer: A Prospective and Observational Cohort Study.
    Loetsch, Felix
    Koenigsbruegge, Oliver
    Posch, Florian
    Zielinski, Christoph
    Pabinger, Ingrid
    Ay, Cihan
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1008 - 1013